Martyn Day – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Martyn Day on 2016-01-12.
To ask the Secretary of State for Health, what assessment he has made of the potential role of technology in reducing aseptic pharmaceutical medication error.
George Freeman
Where appropriate, automation has a role to play in ensuring consistent output from aseptic compounding and increased production capacity. It may also provide additional protection against microbiological contamination by use of ‘closed systems’ of manufacture.
Licensed specials manufacturers may consider automation as an appropriate solution for their product range and capacity. In these cases, Medicines and Healthcare products Regulatory Agency inspections assess whether the process design, validation, personnel, training and procedures relating to the automated system comply with the requirements of Good Manufacturing Practice.
